NSIM
VRTX icon

North Star Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

North Star Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.7K Hold
62
– – ﹤0.01% 851
2025
Q4 		$28.1K Buy
62
+19
+44% +$8.19K ﹤0.01% 790
2025
Q3 		$16.8K Buy
43
+1
+2% +$418 ﹤0.01% 832
2025
Q2 		$18.7K Hold
42
– – ﹤0.01% 797
2025
Q1 		$20.4K Hold
42
– – ﹤0.01% 753
2024
Q4 		$16.9K Buy
42
+13
+45% +$6.03K ﹤0.01% 787
2024
Q3 		$13.5K Buy
29
+14
+93% +$6.72K ﹤0.01% 783
2024
Q2 		$7.03K Hold
15
– – ﹤0.01% 871
2024
Q1 		$6.27K Hold
15
– – ﹤0.01% 943
2023
Q4 		$6.1K Hold
15
– – ﹤0.01% 921
2023
Q3 		$5.22K Hold
15
– – ﹤0.01% 952
2023
Q2 		$5.28K Hold
15
– – ﹤0.01% 962
2023
Q1 		$4.73K Hold
15
– – ﹤0.01% 995
2022
Q4 		$4.33K Buy
15
+10
+200% +$3.05K ﹤0.01% 986
2022
Q3 		$1K Hold
5
– – ﹤0.01% 1108
2022
Q2 		$1K Hold
5
– – ﹤0.01% 1111
2022
Q1 		$1K Hold
5
– – ﹤0.01% 1127
2021
Q4 		$1K Sell
5
-70
-93% -$13.6K ﹤0.01% 1156
2021
Q3 		$14K Hold
75
– – ﹤0.01% 806
2021
Q2 		$15K Buy
+75
New +$15.7K ﹤0.01% 787
2019
Q4 		– Sell
-8
Closed -$1K – 1099
2019
Q3 		$1K Buy
+8
New +$1.42K ﹤0.01% 1069
2015
Q4 		– Sell
-151
Closed -$16K – 848
2015
Q3 		$16K Hold
151
– – ﹤0.01% 533
2015
Q2 		$19K Hold
151
– – ﹤0.01% 499
2015
Q1 		$18K Hold
151
– – ﹤0.01% 501
2014
Q4 		$18K Buy
+151
New +$17K ﹤0.01% 493

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

North Star Investment Management's VRTX Position: Q1 2026 in Review

North Star Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 62 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

North Star Investment Management first reported a position in VRTX in Q4 2014 and has held it in 25 quarters since. The position peaked at $28.1K in Q4 2025. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • North Star Investment Management held 62 shares of Vertex Pharmaceuticals worth $27.7K as of Q1 2026.
  • North Star Investment Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #851 holding.
  • North Star Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 25 quarters since.
  • North Star Investment Management's Vertex Pharmaceuticals position peaked at $28.1K in Q4 2025.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.